-
Flash Session II (C)
Carolina RibeiroDone
-
Poster Session II (w/ Refreshment Break)
Done
-
Flash Session I (C)
Rafaella CoelhoDone
-
Hot Topics II: New biomolecules: Challenges in the development and clinical translation
Carlos Neto, PharmD: Medical Scientific Liaison at Angelini Pharma Portugal and Pedro Madureira, Co-founder and CSO at IMMUNETHEPDone
-
Flash Session II (C)
Ana F. PereiraDone
-
Flash Session III (B)
Andreia MagalhãesDone
-
Openning Session
Done
-
Oral Session I A
Cristiana MateusDone
-
Lunch Break
Done
-
Oral Session I C
Diana GomesDone
Enterprise Plenary Session III
15/02/2023, 09:40
-
15/02/2023, 10:40
(UTC)
(1 hour)
GenIbet Biopharmaceuticals is a company whose mission is to manufacture safe and reliable breakthrough products to support worldwide customers on building the therapies of the future. With a team of more than 50 highly qualified professionals, GenIbet supports its customers on the development and manufacturing of unique novel modalities covering a wide range of technologies.
Sofia Venceslau obtained her Ph.D. degree from the NOVA University of Lisbon, Institute of Chemical and Biological Technology (Oeiras, Portugal) in 2011 and is currently a Project Manager in GenIbet Biopharmaceuticals and will be the third confirmed enterprise speaker for the HSR Congress 2023 on February 15th, 2023.
